Previous Article | Next Article 
Journal of Clinical Microbiology, May 2008, p. 1596-1601, Vol. 46, No. 5
0095-1137/08/$08.00+0 doi:10.1128/JCM.02469-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Genotypic Diversity of Anaerobic Isolates from Bloodstream Infections
Keith E. Simmon,1
Stanley Mirrett,2
L. Barth Reller,2,3 and
Cathy A. Petti1,4*
Associated Regional University Pathologists Laboratories, Salt Lake City, Utah,1
Clinical Microbiology Laboratory, Duke University Hospital,2
Departments of Pathology and Medicine, Duke University School of Medicine, Durham, North Carolina,3
Departments of Pathology and Medicine, University of Utah School of Medicine, Salt Lake City, Utah4
Received 21 December 2007/
Returned for modification 15 February 2008/
Accepted 25 February 2008

ABSTRACT
Accurate species determination for anaerobes from blood culture
bottles has become increasingly important with the reemergence
of anaerobic bacteremia and prevalence of multiple-drug-resistant
microorganisms. Our knowledge of the taxonomical diversity of
anaerobes that cause bloodstream infections is extremely limited,
because identification historically has relied on conventional
methods. Over a 5-year period, we profiled anaerobic bacteremia
at a large tertiary care hospital with 16S rRNA gene sequencing
to gain a better understanding of the taxonomical diversity
of the bacteria. Of 316 isolates, 16S rRNA gene sequencing and
phylogenetic analysis identified 316 (100%) to the genus or
taxonomical group level and 289 (91%) to the species level.
Conventional methods identified 279 (88%) to the genus level
and 208 (66%) to the species level; 75 (24%) were misidentified
at the species level, and 33 (10%) results were inconclusive.
High intragenus variability was observed for
Bacteroides and
Clostridium species, and high intraspecies variability was observed
for
Bacteroides thetaiotaomicron and
Fusobacterium nucleatum.
Sequence-based identification has potential benefits in comparison
to conventional methods, because it more accurately characterizes
anaerobes within taxonomically related clusters and thereby
may enable better correlation with specific clinical syndromes
and antibiotic resistance patterns.

INTRODUCTION
Anaerobic microorganisms remain an important cause of bloodstream
infections and account for 1 to 17% of positive blood cultures
in the United States (
3,
4,
8,
9,
11). The most commonly isolated
pathogens are the
Bacteroides fragilis group, other species
of
Bacteroides,
Peptostreptococcus species, and
Clostridium species (
9). Most laboratories rely on conventional methods
for identification of these common microorganisms and use algorithms
based on key differential biochemical tests (
16). However, DNA
target sequencing has emerged as an attractive alternative,
because identification is faster, more accurate, and independent
of a microorganism's growth characteristics (
10,
15,
17,
18).
Sequence-based identification has enhanced our knowledge about
the taxonomical diversity among anaerobic bacteria and has afforded
the opportunity to better define the epidemiology of anaerobe-associated
diseases. For example, some anaerobes have been associated with
specific clinical syndromes, such as
Clostridium sordellii with
abortion (
1),
Clostridium tertium with neutropenia (
12), and
Fusobacterium necrophorum with hypercoagulability (
5). Additionally,
national surveys have demonstrated increasing antimicrobial
resistance for several anaerobic pathogens (
2,
6,
14), and definitive
species identification can be extremely useful for guiding selection
of empirical antibacterial therapy.
Our knowledge of the taxonomical diversity of anaerobes associated with clinically important bloodstream infections is limited. Most series of anaerobic bacteremia have been based on conventional methods of identification (3, 8, 9, 11), with little or no attention to the genetic diversity within and among genera. Similarly, a systematic approach for identifying the emergence of potentially novel or unusual sequence variants of anaerobes that cause bloodstream infection has not been applied over a 5-year period. We retrospectively studied all anaerobic microorganisms that were recovered from blood cultures at a large, tertiary care hospital. Our aim was to define the spectrum of anaerobes causing bloodstream infections by 16S rRNA gene sequencing and to identify unusual species belonging to taxonomically related groups. Aware that assessing taxonomical diversity relies on representative sequence databases, we specifically used two reference databases and phylogenetic analyses to assess intraspecies, intragenus, and intergenus variability.

MATERIALS AND METHODS
Anaerobic microorganisms recovered from blood cultures between
January 2000 and December 2004 at Duke University Hospital,
Durham, NC, that were deemed clinically significant (
19) were
retrospectively identified. During the study period, all three
major blood culture systems were used: Bactec 9240 (BD Diagnostics,
Sparks, MD), BacT/ALERT (classic and 3D) (bioMérieux,
Inc., Durham, NC), and VersaTREK (Trek Diagnostic Systems, Cleveland,
OH). Duke University Hospital is a large, 924-bed tertiary and
quarternary care facility. Phenotypic identifications were performed
by standard laboratory protocols that included a combination
of manual biochemical testing, use of the API 20A system (bioMérieux,
Marcy l'Etoile, France), and/or use of the Sherlock microbial
identification system (MIDI, Inc., Newark, DE).
16S rRNA gene sequencing.
Bacterial DNA was extracted directly from frozen glycerol preparations of bacteria. The tube contents were thawed for 30 min at room temperature, and 50 µl of stock was removed and placed into molecular-grade water to a final volume of 200 µl. DNA was extracted with the QIAmp DNA minikit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. PCRs were performed in a 20-µl volume containing 1x Taq buffer; 0.25 U of TaKaRa Taq; 3.0 mM MgCl2 (Takara Bio, Inc., Shiga, Japan); 200 µM each dATP, dGTP, and dCTP; 600 µM dUTP (Roche Diagnostics Corporation, Alameda, CA); 0.2 µM of each primer; and 2 µl of template. The primers used for amplification were 5F (5'-TTGGAGAGTTTGATCCTGGCTC-3') and 1194R (5'-ACGTCATCCCCACCTTCCTC-3'). PCR mixtures were amplified by initial holding at 94°C for 5 min and then 30 cycles of denaturing at 94°C for 30 seconds, annealing at 60°C for 30 seconds, and extension at 72°C for 2 min. The reaction ended with a final extension at 72°C for 2 min and a hold at 4°C. The presence and sizes of amplicons were confirmed by gel electrophoresis. PCR products were purified with ExoSAP-IT reagent (USB Corporation, Cleveland, OH) per the manufacturer's instructions. PCR products were bidirectionally sequenced with the original amplification primer, 5F, and a reverse primer, 810R (5'GGCGTGGACTTCCAGGGTATCT-3'). Sequencing reactions were performed with Big Dye terminator reagents on an ABI Prism 310 or 3730xl instrument (Applied Biosystems, Foster City, CA) by a standard automated sequencer protocol.
Sequence and phylogenetic analyses.
Sequences were analyzed with MicroSeq ID software v2.0 (Applied Biosystems). Sequence-based identifications were determined individually with the MicroSeq 16S rDNA 500 Library v2.0 and SmartGene IDNS-Bacteria (version 3.2.3r8) databases (SmartGene, Inc., Raleigh, NC). SmartGene is a web-based application for sequence comparison with a reference database based on GenBank sequences. Alignments and phylogenetic trees were constructed as previously described (13). Final genus- and species-level identifications were assigned by both phylogenetic analysis and the following general guidelines:
99% identity to a reference entry identified a microorganism to the species level, 95.0 to 98.9% identity identified a microorganism to the genus level, and microorganisms with <95% identity to any reference sequence were considered unable to be identified definitively. Multiple species were assigned to isolates when top matches were between 99.0 and 99.9%. When five or more clinical isolates were identified within a group or species, interspecies or intergroup variability was determined by measuring the percent identity and recording the value as the percent difference.

RESULTS
The profile of anaerobes causing clinically significant bacteremia
over the 5-year period is delineated in Table
1.
Sequence-based identification.
Of 316 isolates, 16S rRNA gene sequencing with phylogenetic
analysis identified 316 (100%) to the genus or taxonomical group
level and 289 (91%) to the species level. Of those identified
to the species level, two (0.6%) could not be resolved by sequencing
analysis and were assigned to multiple species,
Clostridium sporogenes/Clostridium botulinum and
Clostridium aerotolerans/Clostridium xylanolyticum.
Identification by conventional methods.
For 316 isolates, conventional methods identified 279 (88%) to the genus level and 208 (66%) to the species level; 75 (24%) were misidentified at the species level, and 33 (10%) of results were inconclusive (Tables 2 and 3).
Analysis of microbial diversity.
Figures
1 and
2 show radial dendrograms illustrating the genetic
diversity of clinical isolates causing bacteremia. Since
Clostridium and
Bacteroides were the most represented groups, it is not
surprising that these genera had the highest intragenus variability,
i.e., 27.5% and 15.4%, respectively. Intraspecies variability
for the most common species of
Clostridium was low: 0.7% for
Clostridium perfringens, 0.2% for
Clostridium tertium, and 0.0%
for
Clostridium ramosum. Intraspecies variabilities for
B. fragilis,
Bacteroides thetaiotaomicron and its relatedness group, and
Bacteroides ovatus were 3.3%, 4.0%, and 0.8%, respectively.
Intraspecies variabilities of
Eggerthella lenta and
Fusobacterium nucleatum were 1.7% and 2.7%, respectively. We observed unusual
sequence variants that grouped within taxonomical clusters of
Anaerococcus sp.,
Bacteroides thetaiotaomicron,
Parabacteroides distasonis,
Bacteroides intestinalis,
Clostridium subterminale,
Eggerthella lenta, and
Peptoniphilus sp. For example, we found
three isolates with sequences that were distinctly different
from reference sequences of
Eggerthella lenta and six sequence
variants for
Bacteroides thetaiotaomicron (Fig.
1 and
2).

DISCUSSION
Accurate species determination for anaerobes from blood cultures
has become increasingly important, because anaerobic bacteremia
with multiple-drug-resistant organisms has emerged as a significant
health care problem as there are more patients at risk from
immunosuppression and multiple comorbidities (
6-
9). To our knowledge,
this study is the first longitudinal survey of anaerobic bacteremia
at a large tertiary care hospital that identified anaerobes
by 16S rRNA gene sequencing. We corroborate previous observations
that the most common anaerobes that cause bloodstream infection,
in decreasing order of frequency, are
Bacteroides fragilis,
other
Bacteroides species,
Clostridium species, anaerobic gram-positive
cocci,
Fusobacterium nucleatum, and
Prevotella spp. Unlike prior
reports that were limited by conventional methods, we observed
with sequence-based identification a significant proportion
of bloodstream infections from less common members of the
Bacteroides and
Clostridium taxonomical groups. We also document the first
cases of anaerobic bacteremia from
Bacteroides dorei,
Bacteroides finegoldii,
Parabacteroides merdae,
Clostridium argentinense,
Clostridium celerecrescens,
Clostridium colicanis,
Ruminococcus gnavus, and
Tissierella praeacuta. Conventional identification
misclassified or inconclusively identified approximately 25%
of isolates, thereby missing a potential opportunity to define
the epidemiology of or susceptibility patterns for these clinically
significant anaerobic bloodstream infections. Of importance,
conventional methods misclassified the Gram reaction and genera
for several isolates and misidentified
Parabacteroides distasonis,
Bacteroides caccae, and
Bacteroides vulgatus, three species
known to have resistance to multiple antibacterials (
14). Clinical
decision-making based on erroneous conventional identifications
could adversely affect patient care if a suboptimal empirical
antibacterial regimen was selected or if misidentification belied
the underlying source of infection.
We acknowledge that many laboratories cannot routinely employ partial 16S rRNA gene sequencing for anaerobic identification due to a lack of technical expertise and to cost. However, over the past several years, various commercial platforms and reference databases have become available for DNA target sequencing, enabling less experienced, nonmolecular bench technologists to determine and analyze DNA sequences. Laboratories should develop algorithms to screen for those isolates that can be adequately identified by conventional methods and should refer only a subset of isolates for 16S rRNA gene sequencing. Additionally, implementation of DNA target sequencing reduces the need for highly experienced personnel, a well-documented diminishing resource, and can result in a labor savings of least one full-time equivalent certified medical technologist (13).
Sequence data are a more valuable tool than identification by conventional methods, because they are objective and can be easily exchanged between different laboratories for comparison. Sequence-based identification enables us to appreciate the degree of heterogeneity within taxa, which can be represented by either high intraspecies variability or unusual sequence variants within taxonomically related clusters. The clinical relevance of reclassifying unusual sequence variants as new species cannot be reliably determined with a single institutional data set. Additionally, phylogeny may vary by the type of DNA target sequenced, with sequences potentially clustering into different groups using 16S rRNA, rpoB, or tuf targets. We propose that investigators maintain viable culture collections of unusual anaerobes and deposit their sequences into public databases, but we caution against the impulse to describe them as unique species. A consensus has not been reached within the microbiology community about drawing finer distinctions between species in a meaningful way, and the concept of species has not been clearly delineated. Instead, we recommend that investigators deposit unusual sequences as "variants within taxonomical relatedness groups," affording the opportunity to carefully evaluate their taxonomical and clinical significance longitudinally and then determine the need for unique species designations. Improved disease surveillance using DNA target sequencing will provide us with the ability to correlate certain anaerobes with specific clinical syndromes and better understand the development of antibiotic resistance within individual taxonomical groups.

FOOTNOTES
* Corresponding author. Mailing address: ARUP Laboratories, 500 Chipeta Way, Salt Lake City, UT 84108. Phone: (801) 583-2787. Fax: (801) 584-5207. E-mail:
cathy.petti{at}aruplab.com 
Published ahead of print on 5 March 2008. 

REFERENCES
1 - Aldape, M. J., A. E. Bryant, and D. L. Stevens. 2006. Clostridium sordellii infection: epidemiology, clinical findings, and current perspectives on diagnosis and treatment. Clin. Infect. Dis. 43:1436-1446.[CrossRef][Medline]
2 - Aldridge, K. E., D. Ashcraft, K. Cambre, C. L. Pierson, S. G. Jenkins, and J. E. Rosenblatt. 2001. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrob. Agents Chemother. 45:1238-1243.[Abstract/Free Full Text]
3 - Blairon, L., Y. De Gheldre, B. Delaere, A. Sonet, A. Bosly, and Y. Glupczynski. 2006. A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital. Clin. Microbiol. Infect. 12:527-532.[CrossRef][Medline]
4 - Diekema, D. J., S. E. Beekmann, K. C. Chapin, K. A. Morel, E. Munson, and G. V. Doern. 2003. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J. Clin. Microbiol. 41:3655-3660.[Abstract/Free Full Text]
5 - Forrester, L. J., B. J. Campbell, J. N. Berg, and J. T. Barrett. 1985. Aggregation of platelets by Fusobacterium necrophorum. J. Clin. Microbiol. 22:245-249.[Abstract/Free Full Text]
6 - Hecht, D. W. 2004. Prevalence of antibiotic resistance in anaerobic bacteria: worrisome developments. Clin. Infect. Dis. 39:92-97.[CrossRef][Medline]
7 - Hecht, D. W. 2007. Routine anaerobic blood cultures: back where we started? Clin. Infect. Dis. 44:901-903.[CrossRef][Medline]
8 - Lark, R. L., S. A. McNeil, K. VanderHyde, A. Noorani, J. Uberti, and C. Chenoweth. 2001. Risk factors for anaerobic bloodstream infections in bone marrow transplant recipients. Clin. Infect. Dis. 33:338-343.[CrossRef][Medline]
9 - Lassmann, B., D. R. Gustafson, C. M. Wood, and J. E. Rosenblatt. 2007. Reemergence of anaerobic bacteremia. Clin. Infect. Dis. 44:895-900.[CrossRef][Medline]
10 - Lau, S. K. P., P. C. Y. Woo, A. M. Y. Fung, K. Chan, G. K. S. Woo, and K. Yuen. 2004. Anaerobic, non-sporulating, gram-positive bacilli bacteremia characterized by 16S rRNA gene sequencing. J. Med. Microbiol. 53:1247-1253.[Abstract/Free Full Text]
11 - Lombardi, D. P., and N. C. Engleberg. 1992. Anaerobic bacteremia: incidence, patient characteristics, and clinical significance. Am. J. Med. 92:53-60.[CrossRef][Medline]
12 - Miller, D. L., S. Brazer, D. Murdoch, L. B. Reller, and G. R. Corey. 2001. Significance of Clostridium tertium bacteremia in neutropenic and nonneutropenic patients: review of 32 cases. Clin. Infect. Dis. 32:975-978.[CrossRef][Medline]
13 - Simmon, K. E., A. C. Croft, and C. A. Petti. 2006. Application of SmartGene IDNS software to partial 16S rRNA gene sequences for a diverse group of bacteria in a clinical laboratory. J. Clin. Microbiol. 44:4400-4406.[Abstract/Free Full Text]
14 - Snydman, D. R., N. V. Jacobus, L. A. McDermott, R. Ruthazer, Y. Golan, E. J. C. Goldstein, S. M. Finegold, L. J. Harrell, D. W. Hecht, S. G. Jenkins, C. Pierson, R. Venezia, V. Yu, J. Rihs, and S. L. Gorbach. 2007. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob. Agents Chemother. 51:1649-1655.[Abstract/Free Full Text]
15 - Song, Y., C. Liu, M. Bolanos, J. Lee, M. McTeague, and S. M. Finegold. 2005. Evaluation of 16S rRNA sequencing and reevaluation of a short biochemical scheme for identification of clinically significant Bacteroides species. J. Clin. Microbiol. 43:1531-1537.[Abstract/Free Full Text]
16 - Song, Y., C. Liu, and S. M. Finegold. 2007. Development of a flow chart for identification of gram-positive anaerobic cocci in the clinical laboratory. J. Clin. Microbiol. 45:512-516.[Abstract/Free Full Text]
17 - Song, Y., C. Liu, and S. M. Finegold. 2007. Peptoniphilus gorbachii sp. nov., Peptoniphilus olsenii sp. nov., and Anaerococcus murdochii sp. nov. isolated from clinical specimens of human origin. J. Clin. Microbiol. 45:1746-1752.[Abstract/Free Full Text]
18 - Song, Y., C. Liu, M. McTeague, and S. M. Finegold. 2003. 16S ribosomal DNA sequence-based analysis of clinically significant anaerobic cocci. J. Clin. Microbiol. 41:1363-1369.[Abstract/Free Full Text]
19 - Weinstein, M. P., M. L. Towns, S. M. Quartey, S. Mirrett, L. G. Reimer, G. Parmigiani, and L. B. Reller. 1997. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin. Infect. Dis. 24:584-602.[Medline]
Journal of Clinical Microbiology, May 2008, p. 1596-1601, Vol. 46, No. 5
0095-1137/08/$08.00+0 doi:10.1128/JCM.02469-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Sakamoto, M., Suzuki, N., Matsunaga, N., Koshihara, K., Seki, M., Komiya, H., Benno, Y.
(2009). Parabacteroides gordonii sp. nov., isolated from human blood cultures. Int. J. Syst. Evol. Microbiol.
59: 2843-2847
[Abstract]
[Full Text]